Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Cellectis S.A. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q4 2025
- Shares held
- 10.2M
- −292.0K (−2.8%) vs. Q4 2025
- Total value
- $32.5M
- −$18.5M (−36.3%) vs. Q4 2025
- New holders
- 4
- 3 more added
- Sold out
- 5
- 14 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $3 | 0.00% | −2,557−100.0% | Reduced |
| CWM Advisors, LLC | 6 | $19 | 0.00% | −2−25.0% | Reduced |
| EverSource Wealth Advisors, LLC | 13 | $41 | 0.00% | −183−93.4% | Reduced |
| Larson Financial Group LLC | 75 | $238 | 0.00% | +75 | New |
| Group One Trading, L.P. | 97 | $307 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $317 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 224 | $710 | 0.00% | +224 | New |
| POM Investment Strategies, LLC | 495 | $1.57K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 500 | $1.58K | 0.00% | −154−23.5% | Reduced |
| GAMMA Investing LLC | 734 | $2.33K | 0.00% | −373−33.7% | Reduced |
| Quadrant Capital Group LLC | 944 | $2.99K | 0.00% | −1,817−65.8% | Reduced |
| Atlantic Union Bankshares Corp | 1,500 | $4.75K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,797 | $5.70K | 0.00% | +664+58.6% | Added |
| Wells Fargo & Company | 3,150 | $9.99K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $11.1K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 4,500 | $14.3K | 0.00% | 00.0% | Unchanged |
| Lido Advisors, LLC | 10,094 | $32.0K | 0.00% | +10,094 | New |
| Rhumbline Advisers | 15,085 | $47.8K | 0.00% | +1,742+13.1% | Added |
| XTX Topco Ltd | 16,269 | $51.6K | 0.00% | +16,269 | New |
| Delaney Dennis R | 24,000 | $76.1K | 0.03% | 00.0% | Unchanged |
| UBS Group AG | 29,774 | $94.4K | 0.00% | −20,326−40.6% | Reduced |
| BNP Paribas Arbitrage, SA | 41,000 | $130.0K | 0.00% | −300−0.7% | Reduced |
| Marshall Wace, LLP | 41,112 | $130.3K | 0.00% | −137,361−77.0% | Reduced |
| Citadel Advisors LLC | 44,315 | $140.5K | 0.00% | −51,112−53.6% | Reduced |
| Susquehanna International Group, LLP | 65,942 | $209.0K | 0.00% | +13,519+25.8% | Added |
| LPL Financial LLC | 84,345 | $267.4K | 0.00% | −447−0.5% | Reduced |
| Morgan Stanley | 86,776 | $275.1K | 0.00% | −400−0.5% | Reduced |
| Nomura Asset Management International Inc. | 226,875 | $719.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 341,523 | $1.08M | 0.00% | −42,776−11.1% | Reduced |
| Long Focus Capital Management, LLC | 2,744,098 | $8.70M | 0.38% | −43,652−1.6% | Reduced |
| UBS Asset Management Americas Inc | 3,178,620 | $10.1M | 0.00% | 00.0% | Unchanged |
| B Group, Inc. | 3,281,501 | $10.4M | 7.71% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −27,314−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −3,514−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −1,479−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −662−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |